Proposals for the measurement of anti-β2-glycoprotein I antibodies.: Standardization group of the European forum on antiphospholipid antibodies

被引：120
作者：
Reber, G [1 ]
Tincani, A
Sanmarco, M
de Moerloose, P
Boffa, MC
机构：
[1] Univ Hosp Geneva, Haemostasis Unit, CH-1211 Geneva 14, Switzerland
[2] Brescia Hosp, Clin Immunol Unit, Brescia, Italy
[3] Hop Conception, Immunol Lab, Marseille, France
[4] Hop Pitie, Dept Internal Med JC Piette, Paris, France
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2004年 / 2卷 / 10期
关键词：
D O I：
10.1111/j.1538-7836.2004.00910.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1860 / 1862
页数：3
相关论文
共 15 条
[1]  
CABIEDES J, 1995, J RHEUMATOL, V22, P1899
[2]   Prevalence of anticardiolipin and antinuclear antibodies in an elderly hospitalized population and mortality after a 6-year follow-up [J].
deMoerloose, P ;
Boehlen, F ;
Reber, G ;
Dechevrens, O ;
Herrmann, F ;
Michel, JP .
AGE AND AGEING, 1997, 26 (04) :319-320
[3]   Assessing the usefulness of anticardiolipin antibody assays - A cautious approach is suggested by high variation and limited consensus in multilaboratory testing [J].
Favaloro, EJ ;
Silvestrini, R .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) :548-557
[4]   ANTICARDIOLIPIN ANTIBODIES (ACA) DIRECTED NOT TO CARDIOLIPIN BUT TO A PLASMA-PROTEIN COFACTOR [J].
GALLI, M ;
COMFURIUS, P ;
MAASSEN, C ;
HEMKER, HC ;
DEBAETS, MH ;
VANBREDAVRIESMAN, PJC ;
BARBUI, T ;
ZWAAL, RFA ;
BEVERS, EM .
LANCET, 1990, 335 (8705) :1544-1547
[5]   THE 2ND INTERNATIONAL ANTICARDIOLIPIN STANDARDIZATION WORKSHOP THE KINGSTON ANTIPHOSPHOLIPID ANTIBODY STUDY (KAPS) GROUP [J].
HARRIS, EN .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 94 (04) :476-484
[6]  
Ichikawa K, 1999, ARTHRITIS RHEUM, V42, P2461, DOI 10.1002/1529-0131(199911)42:11<2461::AID-ANR25>3.0.CO
[7]  
2-O
[8]   ANTICARDIOLIPIN COFACTOR(S) AND DIFFERENTIAL-DIAGNOSIS OF AUTOIMMUNE-DISEASE [J].
MATSUURA, E ;
IGARASHI, Y ;
FUJIMOTO, M ;
ICHIKAWA, K ;
KOIKE, T .
LANCET, 1990, 336 (8708) :177-178
[9]   ANTIPHOSPHOLIPID ANTIBODIES ARE DIRECTED AGAINST A COMPLEX ANTIGEN THAT INCLUDES A LIPID-BINDING INHIBITOR OF COAGULATION - BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H) [J].
MCNEIL, HP ;
SIMPSON, RJ ;
CHESTERMAN, CN ;
KRILIS, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4120-4124
[10]  
Reber G, 2002, THROMB HAEMOSTASIS, V88, P66
12